Nature Reviews Urology

Papers
(The H4-Index of Nature Reviews Urology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything222
Texture analysis for patient selection210
Single-cell and spatial sequencing of kidney cancer158
Human-relevant urothelial model provides insight into infection strategies and host response143
Krause corpuscles act as genital vibration detectors129
Semen quality recovery following COVID-19102
PARP inhibitors plus enzalutamide to treat mCRPC86
Urine microbiota differ in bladder cancer81
Considering urology in a planetary context80
Time for women-centred gynaecology76
The clinical utility of prostate MRI before biopsy75
Advancing the state of the art in congenital obstructive uropathy75
Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network73
Preclinical models of bladder cancer: BBN and beyond72
High-dose chemotherapy for relapsed testicular germ cell tumours66
A clinical guide to rare male sexual disorders62
Micro-ultrasound for prostate cancer60
FOXA2–KIT-driven lineage plasticity in NEPC58
Proteomic-based analysis of testicular interstitial fluid58
A new text message-based platform for self-management of patients with IC/BPS57
Overcoming antibiotic resistance in complicated UTI57
Madrid plays host to a celebration of urology55
What happens in Vegas … shapes the future of urology53
Microfluidic sperm selection51
Promise without practice — charting the path forward for bladder cancer biomarkers50
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations50
Leveraging generative AI to enhance doctor–patient communication50
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers48
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer48
Metaverse in surgery — origins and future potential47
Pembrolizumab + axitinib beyond first-line therapy for mRCC46
A non-invasive assay for UTUC diagnosis46
COVID can’t kill CopMich collaboration43
Vaccination to prevent untreatable gonorrhoea42
The mechanism of action of neuromodulation in the treatment of overactive bladder41
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility41
Measuring and improving the cradle-to-grave environmental performance of urological procedures41
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology37
Personalized 3D models for prostate cancer surgery37
0.21079206466675